Frontlight ResearchEarly access
Trial site
Nizhny Novgorod
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Hidradenitis suppurativa1 trial
- Melanoma1 trial
- Multiple sclerosis1 trial
- Psoriasis1 trial
- Phase
- Phase 32 trials
- Status
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
Running trials
Active, not recruiting
Active, not recruiting
Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026